Industry focus
At the heart of my patent law practice is a commitment to client-first advocacy. I believe that every invention is more than a technical achievement—it’s a reflection of human ingenuity and ambition. My role is to translate that vision into robust legal protection, guiding clients with clarity, strategy, and unwavering dedication to their goals.
How I represent clients at Schwabe
I help clients navigate the complex world of patent prosecution, ensuring their innovations in life sciences, biotechnology, medical devices, and chemistry are protected and positioned for success. With 10 years of experience before the USPTO, I’ve developed a deep understanding of the patent preparation, filing, and prosecution process, as well as patentability searches, invalidity opinions, and portfolio management. In a few short years, I’ve successfully secured approximately 120 patents worldwide, including 70 in the United States.
With a strong foundation in molecular biology, biochemistry, structural biology, and bioengineering, paired with over 10 years in patent law, I bring a practical and solutions-driven approach to every project. From drafting applications to managing portfolios and addressing nuanced legal challenges, I’m committed to helping clients turn groundbreaking ideas into secured assets that drive their businesses forward.
Experience
- 10 years of patent prosecution experience in biotechnology, medical devices, and chemistry.
- Invalidity opinion letters.
- Patent prosecution counselling.
- Patent portfolio management and due diligence.
- FTO and prior art searches.
Education
- Mitchell Hamline School of Law, Juris Doctor (2024)
- Rutgers University, Ph.D. (2008)
- University of Science and Technology of China, (2002)
- NanChang University, Bachelor of Science (1997)
Admissions
- Minnesota State Courts
- United States Patent and Trademark Office
Awards
Cum Laude (2024), Mitchell Hamline School of Law
Dean’s list (2022-2024), Mitchell Hamline School of Law
Additional Publications
Tu, Xiongying (2025) “CHINA’S UTILITY MODEL SYSTEM: A FRAMEWORK TAILORED TO THE COUNTRY’S SPECIFIC ECONOMIC AND DEVELOPMENTAL CONTEXTS AND OBJECTIVES,” American Intellectual Property Law Association Quarterly Journal · Jun 23, 2025
Tu, Xiongying (2024) “Disharmony in Patent Law: A Comparative Study of Patent Eligibility of Biological Subject Matters Between China and the United States,” Cybaris®: Vol. 15: Iss. 1, Article 4.
Services
Sign up